<DOC>
	<DOCNO>NCT01658657</DOCNO>
	<brief_summary>The purpose study investigate effect plasma renin activity-guided therapy determine hypertension treatment . Plasma renin enzyme blood measure determine hypertension subtype . Once subtype know , doctor prescribe specific medication target specific hypertension subtype . This study investigate whether target specific hypertension subtype help achieve blood pressure control sooner few medication compare standard fix dose combination therapy .</brief_summary>
	<brief_title>A Pilot Study Plasma Renin Activity Guided v Generic Combination Therapy Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Systolic BP average least one recent ( within 1 month ) clinic emergency room visit ≥ 150 mmHg , diastolic BP average least one recent ( within 1 month ) clinic emergency room visit ≥ 95 mmHg Not currently take BPlowering medication Clinician recommend pharmacologic treatment Willing make necessary study visit Able contact phone Has primary care clinician At least 18 year old Known secondary cause hypertension Pregnancy Known diabetes , coronary artery disease renal disease Known sulfonamide allergy history gout Participant 's clinician recommend he/she enroll Hyponatremia , hypokalemia , hypernatremia , hyperglycemia baseline visit Baseline visit systolic visit BP average &lt; 140 mmHg diastolic BP average &lt; 90 mm Hg Resting heart rate &lt; 55 beat per minute</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>